Paper - WANFANG MED ONLINE

You Position: Home > Paper

Research progress of risk factors in bloodstream infection caused by carbapenem-resistant Klebsiella penumoniae

( views:0, downloads:0 )

Author:: No author available

Journal Title:: Chinese Journal of Clinical Infectious Diseases

Issue:: 3

DOI:: 10.3760/cma.j.issn.1674-2397.2021.03.014

Key Word:: 血流感染;碳青霉烯耐药肺炎克雷伯菌;危险因素;Bloodstream infection;Carbapenem-resistant Klebsiella penumoniae;Risk factors

Abstract： Bloodstream infection (BSI) is a systemic infectious disease. The incidence and mortality of BSI caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) remain high, which brought severe challenges into clinical anti-infection treatment and enormous economic burdens for the patients. This article reviews the current research progress on risk factors of BSI caused by CRKP, hoping to provide reference for the early diagnosis and treatment of this disease.

Reference

[1]Leibman Violet,Martin Emily T.,Tal-Jasper Ruthy,etc.Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae[J].2015,14(1).
[2]Jihong,Li,Yuanyuan,Li,Ning,Song,etc.Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis.[J].2019.
[3]Brink, Adrian J..Epidemiology of carbapenem-resistant Gram-negative infections globally[J].2019,32(6).
[4]Zhang Ye,Guo Ling-Yun,Song Wen-Qi,etc.Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients[J].2018,18(1).
[5]Haiyan,Chang,Jie,Wei,Wanqing,Zhou,etc.Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.[J].2020,13(5).
[6]Maria Luisa, Cristina,Cristiano, Alicino,Marina, Sartini,etc.Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.[J].2017,(Spec ).
[7]Tian Lijun,Tan Ruoming,Chen Yang,etc.Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality[J].2016,5(1).
[8]Xiao, Tingting,Zhu, Yunying,Zhang, Shuntian,etc.A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients[J].2020,221(Suppl.2).
[9]Yijun,Ding,Yajuan,Wang,Yingfen,Hsia,etc.Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.[J].2019,18(1).
[10]Raz-Pasteur,A.,Hussein,K.,Finkelstein,R.,etc.Blood stream infections (BSI) in severe burn patients-early and late BSI: A 9-year study[J].2013,39(4).
[11]Giannella, Maddalena,Graziano, Elena,Marconi, Lorenzo,etc.Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study[J].2017,36(10).
[12]Youhua,Yuan,Junjie,Wang,Zonghui,Yao,etc.Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes.[J].2020,13.
[13]Hanghui, Cen,Zhenbo, Wu,Fan, Wang,etc.Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China.[J].2015,8.
[14]Micozzi Alessandra,Gentile Giuseppe,Minotti Clara,etc.Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias[J].2017,17(1).
[15].Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy[J].2020,42(3).
[16]Li Yuanyuan,Li Jihong,Hu Tong,etc.Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China[J].2020,9(1).
[17]Philipp P, Kohler,Cheryl, Volling,Karen, Green,etc.Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.[J].2017,38(11).
[18]Amit, S.,Mishali, H.,Kotlovsky, T.,etc.Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors[J].2015,21(1).
[19]Giacobbe, D. R.,Del Bono, V.,Bruzzi, P.,etc.Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study[J].2017,36(4).
[20]Jianling Liu,Haichen Wang,Ziyan Huang,etc.Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients[J].2019,13(5).
[21]Giannella, M.,Trecarichi, E. M.,De Rosa, F. G.,etc.Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study[J].2014,20(12).